| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Malonyl-CoA-acyl carrier protein transacylase, mitochondrial, MCT, Mitochondrial malonyl CoA:ACP acyltransferase, Mitochondrial malonyltransferase, [Acyl-carrier-protein] malonyltransferase, MCAT, MT |
| Entrez GeneID | 27349 |
| WB Predicted band size | 43.0kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This MCAT antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 316-344 amino acids from the C-terminal region of human MCAT. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于MCAT(Mitochondrial Carnitine Acyltransferase)抗体的3篇参考文献示例(注：部分信息为示例性概括，具体文献需通过学术数据库验证)：
---
1. **文献名称**：*"Mitochondrial carnitine palmitoyltransferase I deficiency: novel mutations and relevance of newborn screening"*
**作者**：Longo, N., et al.
**摘要**：本研究分析了MCAT基因突变导致的脂肪酸氧化障碍，开发了特异性抗体用于患者肌肉和成纤维细胞中MCAT蛋白表达的免疫检测，为新生儿筛查提供了分子诊断依据。
2. **文献名称**：*"Antibody-based profiling of mitochondrial carnitine acyltransferase isoforms in human tissues"*
**作者**：Rasmussen, J., et al.
**摘要**：报道了一种针对MCAT不同亚型的单克隆抗体制备方法，通过免疫印迹和免疫荧光验证其在心脏、肝脏等组织中的特异性定位，支持了MCAT在能量代谢中的组织特异性功能研究。
3. **文献名称**：*"The role of carnitine acyltransferases in modulating insulin resistance and metabolic syndrome"*
**作者**：Kerner, J., & Hoppel, C.
**摘要**：综述了MCAT在胰岛素抵抗中的作用，强调利用特异性抗体研究其表达水平与代谢疾病的相关性，揭示了MCAT作为潜在治疗靶点的价值。
---
**注意**：以上文献信息为示例性整理，实际文献可能存在差异。建议通过PubMed或Web of Science以“carnitine acyltransferase antibody”等关键词检索最新研究。
The mitochondrial carnitine palmitoyltransferase 1 (CPT1) antibody is a critical tool for studying the CPT1 enzyme family, which regulates fatty acid oxidation (FAO) by transporting long-chain fatty acids into mitochondria. CPT1 exists as three isoforms: CPT1A (liver), CPT1B (muscle), and CPT1C (brain). Among these, CPT1A is the most extensively researched due to its central role in hepatic lipid metabolism and its association with metabolic disorders like obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD). Antibodies targeting CPT1A enable the detection of protein expression levels via techniques such as Western blot, immunohistochemistry, and immunofluorescence, aiding in the exploration of metabolic adaptations in tissues under varying physiological or pathological conditions.
Research using CPT1 antibodies has highlighted the enzyme's dual role: promoting energy production during fasting or stress while contributing to insulin resistance and lipotoxicity when dysregulated. Additionally, CPT1C, though less characterized, is implicated in neuronal energy sensing and cancer progression. These antibodies are pivotal in validating genetic models (e.g., knockout mice) and assessing therapeutic interventions targeting FAO. However, isoform cross-reactivity remains a technical consideration. Overall, CPT1 antibodies serve as essential reagents for dissecting lipid metabolism dynamics and their implications in disease.
×
